Share Capital (Details Textual) $ / shares in Units, $ in Thousands		12 Months Ended
	May 23, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) vote $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Sep. 30, 2023 shares	May 11, 2023 shares	Mar. 01, 2023 USD ($)
Share Capital [Line Items]
Stock Repurchased and Retired During Period, Shares | shares		9,900,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $		$ 138,600
Stock Repurchased and Retired During Period | $ / shares		$ 6.00
Stock Repurchase Program, Increase in Authorized Amount | $							$ 125,000
Stock Repurchase Program, Authorized Amount | $							$ 250,000
Stock Repurchased During Period, Shares | shares	23,300,000
Stock Repurchased During Period, Value | $	$ 150,000
Stock Repurchased During Period, Per Share | $ / shares	$ 6.43
Class C Common Stock exchanged for Class A Common Stock | shares						9,300,000
ESPP Maximum Eligible Percentage Withheld					15.00%
Repurchase of Common Stock under Repurchase Program | $		$ 59,500
Common Stock, Capital Shares Reserved for Future Issuance | shares		6,500,000	12,900,000
Stock-based compensation | $		$ 57,179	$ 33,152	$ 75,032
Increase (Decrease) in Profit Interest Award, Liability | $		$ 3,900	$ (4,200)
Stock Appreciation Rights (SARs)
Share Capital [Line Items]
RSUs outstanding (shares) | shares		3,122,000	4,845,000
Grant date fair value of options granted (in dollars per share) | $ / shares		$ 2.59	$ 2.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price | $ / shares		$ 5.74	$ 4.57
Granted (in shares) | shares		225,000
Exercised (in shares) | shares		(1,948,000)
Weighted average grant date fair value, granted (in dollars per share) | $ / shares		$ 2.23		$ 2.39
Weighted average exercise price, granted (in dollars per share) | $ / shares		6.79
Weighted average grant date fair value, exercised (in dollars per share) | $ / shares		3.02
Weighted average exercise price, exercised (in dollars per share) | $ / shares		$ 2.93
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		5.00%		1.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%		0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		0 years
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $		$ 400
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares | shares		500,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition		1 year 7 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms		1 year 7 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $		$ 5,300
SARs Modification expense | $		4,400
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | $		8,100	$ 100
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value | $		$ 5,300
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares		$ 5.12
Stock Appreciation Rights (SARs) | Minimum
Share Capital [Line Items]
Grant date fair value of options granted (in dollars per share) | $ / shares				$ 2.20
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		0 years		2 years 9 months 18 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		26.70%		35.50%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		2 months 12 days
Stock Appreciation Rights (SARs) | Maximum
Share Capital [Line Items]
Grant date fair value of options granted (in dollars per share) | $ / shares				$ 3.66
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		3 years		4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		42.10%		38.10%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		4 years
Restricted Stock and Restricted Stock Units
Share Capital [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $		$ 38,400	$ 77,300	$ 1,500
Time-Based Awards
Share Capital [Line Items]
RSUs outstanding (shares) | shares		7,172,000	6,269,000
Grant date fair value of options granted (in dollars per share) | $ / shares		$ 7.23	$ 7.07
Granted (in shares) | shares		6,595,000
Weighted average grant date fair value, granted (in dollars per share) | $ / shares		$ 7.19	$ 7.38	$ 5.51
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $		$ 21,300
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition		8 months 1 day
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms		8 months 1 day
Performance-Based Awards
Share Capital [Line Items]
RSUs outstanding (shares) | shares		3,711,000	2,386,000
Grant date fair value of options granted (in dollars per share) | $ / shares		$ 7.56	$ 7.74
Granted (in shares) | shares		1,328,000
Weighted average grant date fair value, granted (in dollars per share) | $ / shares		$ 7.24	$ 8.68	$ 7.03
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $		$ 12,300
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition		1 year 3 months 29 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms		1 year 3 months 29 days
Stock Compensation Award
Share Capital [Line Items]
Stock-based compensation | $		$ 51,200	$ 36,700	$ 75,000
Share-Based Payment Arrangement, Noncash Expense, Income Tax Benefit | $		$ 13,000	4,100	$ 5,300
Stock Appreciation Rights Granted in 2023
Share Capital [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		4.60%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period		5 years
Stock Appreciation Rights Granted in 2023 | Minimum
Share Capital [Line Items]
Grant date fair value of options granted (in dollars per share) | $ / shares		$ 2.10
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		3 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		34.60%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		1 year
Stock Appreciation Rights Granted in 2023 | Maximum
Share Capital [Line Items]
Grant date fair value of options granted (in dollars per share) | $ / shares		$ 2.35
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		36.70%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		3 years
Other Awards
Share Capital [Line Items]
Profit interest award liability | $		$ 20,300	$ 21,000
Common Class A
Share Capital [Line Items]
Common Stock, Shares Authorized | shares		1,000,000,000
Common Stock, Shares, Issued | shares		118,500,000
Common stock, voting rights, number of votes per share | vote		1
Employee Stock Ownership Plan (ESOP), Shares in ESOP | shares					2,900,000
Stock Issued During Period, Shares, Employee Stock Ownership Plan | shares		3,000,000
Common Class C
Share Capital [Line Items]
Common Stock, Shares Authorized | shares		250,000,000
Common Stock, Shares, Outstanding | shares		151,600,000